The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Transdermal patches: history, development and pharmacology
Open accessAbstract
Transdermal patches are now widely used as cosmetic, topical and transdermal delivery systems. These patches represent a key outcome from the growth in skin science, technology and expertise developed through trial and error, clinical observation and evidence‐based studies that date back to the first existing human records. This review begins with the earliest topical therapies and traces topical delivery to the present‐day transdermal patches, describing along the way the initial trials, devices and drug delivery systems that underpin current transdermal patches and their actives. This is followed by consideration of the evolution in the various patch designs and their limitations as well as requirements for actives to be used for transdermal delivery. The properties of and issues associated with the use of currently marketed products, such as variability, safety and regulatory aspects, are then described. The review concludes by examining future prospects for transdermal patches and drug delivery systems, such as the combination of active delivery systems with patches, minimally invasive microneedle patches and cutaneous solutions, including metered‐dose systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lane, M. E. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.040 · Cited by 1,486
Current status and future potential of transdermal drug delivery
Prausnitz, M. R., Mitragotri, S., & Langer, R. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1304 · Cited by 1,462
Scheuplein, R. J., & Blank, I. H. (1971) · Physiological Reviews · doi:10.1152/physrev.1971.51.4.702 · Cited by 1,398
Metabolism and Disposition Kinetics of Nicotine
Hukkanen, J., Jacob, P., & Benowitz, N. L. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.3 · Cited by 1,321
Nitric oxide in immunity and inflammation
Coleman, J. W. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00086-8 · Cited by 945
Pawson, A. J., Sharman, J. L., Benson, H. E., Faccenda, E., Alexander, S. P. H., Buneman, O. P., Davenport, A. P., McGrath, J. C., Peters, J. A., Southan, C., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1143 · Cited by 849
Drug permeation through human skin: Theory and invitro experimental measurement
Michaels, A. S., Chandrasekaran, S. K., & Shaw, J. E. (1975) · AIChE Journal · doi:10.1002/aic.690210522 · Cited by 801
ACR guidance document on MR safe practices: 2013
Safety:, E. P. O. M., Kanal, E., Barkovich, A. J., Bell, C., Borgstede, J. P., Bradley, W. G., Froelich, J. W., Gimbel, J. R., Gosbee, J. W., Kuhni‐Kaminski, E., et al. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24011 · Cited by 761
The origins and evolution of “controlled” drug delivery systems
Hoffman, A. S. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.08.012 · Cited by 738
Transdermal drug delivery: overcoming the skin’s barrier function
Naik, A., Kalia, Y. N., & Guy, R. H. (2000) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(00)00295-9 · Cited by 720
Self-citationA 100,000-Year-Old Ochre-Processing Workshop at Blombos Cave, South Africa
Henshilwood, C. S., d’Errico, F., van Niekerk, K. L., Coquinot, Y., Jacobs, Z., Lauritzen, S.-E., Menu, M., & García-Moreno, R. (2011) · Science · doi:10.1126/science.1211535 · Cited by 601
Feldmann, R. J., & Maibach, H. I. (1967) · Journal of Investigative Dermatology · doi:10.1038/jid.1967.29 · Cited by 555
Passive skin penetration enhancement and its quantification in vitro
Moser, K. (2001) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(01)00166-7 · Cited by 553
Ancient Egyptian Materials and Industries
James, T. G. H., Lucas, A., & Harris, J. R. (1963) · The Journal of Egyptian Archaeology · doi:10.2307/3855727 · Cited by 549
Ancient Egyptian Materials and Industries
Sloley, R. W. (1948) · The Journal of Egyptian Archaeology · doi:10.1177/030751334803400129 · Cited by 547
MEXILETINE FOR TREATMENT OF CHRONIC PAINFUL DIABETIC NEUROPATHY
Dejgard, A., Petersen, P., & Kastrup, J. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90999-3 · Cited by 530
Poewe, W. H., Rascol, O., Quinn, N., Tolosa, E., Oertel, W. H., Martignoni, E., Rupp, M., & Boroojerdi, B. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70108-4 · Cited by 398
Dermal Absorption and Toxicity Assessment
(2007) · CRC Press eBooks · doi:10.3109/9780849375927 · Cited by 340
Dermatological and Transdermal Formulations
(2002) · CRC Press eBooks · doi:10.1201/9780824743239 · Cited by 323
Microneedles permit transdermal delivery of a skin-impermeant medication to humans
Wermeling, D. P., Banks, S. L., Hudson, D. A., Gill, H. S., Gupta, J., Prausnitz, M. R., & Stinchcomb, A. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710355105 · Cited by 311
Aragona, M., Macagno, S., Caredda, F., Crivelli, O., Lavarini, C., Maran, E., Farci, P., Rh, P., & Rizzetto, M. (1987) · The Lancet · Cited by 286
Powers, M. S., Schenkel, L., Darley, P. E., Good, W. R., Balestra, J. C., & Place, V. A. (1985) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(85)90569-1 · Cited by 283
Transdermal drug delivery: 30 + years of war and still fighting!
Wiedersberg, S., & Guy, R. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.022 · Cited by 278
Development of Skin Barrier Function in Premature Infants
Kalia, Y. N., Nonato, L. B., Lund, C. H., & Guy, R. H. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00289.x · Cited by 277
Self-citationForbes, R. J. (1972) · BRILL eBooks · doi:10.1163/9789004675742 · Cited by 276
Human Pharmacokinetics of Intravenous, Sublingual, and Buccal Buprenorphine
Kuhlman, J. J., Lalani, S., Magluilo, J., Levine, B., Darwin, W. D., Johnson, R. E., & Cone, E. J. (1996) · Journal of Analytical Toxicology · doi:10.1093/jat/20.6.369 · Cited by 273
Molecular Size as the Main Determinant of Solute Maximum Flux Across the Skin
Magnusson, B. M., Anissimov, Y. G., Cross, S. E., & Roberts, M. S. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22413.x · Cited by 244
Self-citationDaddona, P. E., Matriano, J. A., Mandema, J., & Maa, Y.-F. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0192-9 · Cited by 234
Cutaneous Pharmacokinetics: 10 Steps to Percutaneous Absorption
Wester, R. C., & Maibach, H. I. (1983) · Drug Metabolism Reviews · doi:10.3109/03602538308991388 · Cited by 232
The Papyrus Ebers; The Greatest Egyptian Medical Document
Dawson, W. R., & Ebbell, B. (1938) · The Journal of Egyptian Archaeology · doi:10.2307/3854804 · Cited by 224
Permeability of human epidermis to phenolic compounds
Roberts, M. S., Anderson, R. A., & Swarbrick, J. (1977) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1977.tb11434.x · Cited by 221
Self-citationHOLLEY, F. O., & VAN STEENNIS, C. (1988) · British Journal of Anaesthesia · doi:10.1093/bja/60.6.608 · Cited by 208
Pressure-sensitive adhesives for transdermal drug delivery systems
Tan, H. S., & Pfister, W. R. (1999) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(99)00119-4 · Cited by 204
Transdermal fentanyl: Pharmacology and toxicology
Nelson, L., & Schwaner, R. (2009) · Journal of Medical Toxicology · doi:10.1007/bf03178274 · Cited by 197
Sittl, R. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)90019-1 · Cited by 186
Meikle, A. W. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.3.623 · Cited by 185
Peet, T. E. (1931) · The Journal of Egyptian Archaeology · doi:10.1177/030751333101700126 · Cited by 183
Functional skin adaptation in infancy – almost complete but not fully competent
Fluhr, J. W., Darlenski, R., Taieb, A., Hachem, J., Baudouin, C., Msika, P., De Belilovsky, C., & Berardesca, E. (2010) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.01023.x · Cited by 178
Geller, M. J. (2010) · Wiley eBooks · doi:10.1002/9781444319996 · Cited by 176
The role of microneedles for drug and vaccine delivery
Quinn, H. L., Kearney, M.-C., Courtenay, A. J., McCrudden, M. T., & Donnelly, R. F. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.938635 · Cited by 174
Fernando, G. J. P., Chen, X., Prow, T. W., Crichton, M. L., Fairmaid, E. J., Roberts, M. S., Frazer, I. H., Brown, L. E., & Kendall, M. A. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010266 · Cited by 172
Self-citationThe Concise Guide to PHARMACOLOGY 2013/14: Overview
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., McGrath, J. C., Catterall, W. A., Spedding, M., Peters, J. A., Harmar, A. J., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12444 · Cited by 168
Interindividual variability in the metabolism and cardiovascular effects of nicotine in man.
Benowitz, N. L., Jacob, P., Jones, R. T., & Rosenberg, J. (1982) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33068-5 · Cited by 168
Clinical Pharmacokinetics of Clonidine
Lowenthal, D. T., Matzek, K. M., & MacGregor, T. R. (1988) · Clinical Pharmacokinetics · doi:10.2165/00003088-198814050-00002 · Cited by 162
PLASMA FENTANYL CONCENTRATIONS DURING TRANSDERMAL DELIVERY OF FENTANYL TO SURGICAL PATIENTS
Duthie, D. J. R., Rowbotham, D. J., WYLD, R., et al. (1988) · British Journal of Anaesthesia · doi:10.1093/bja/60.6.614 · Cited by 154
Screening for hypothyroidism in elderly inpatients.
Bahemuka, M., & HODKINSON, H. M. (1975) · BMJ · doi:10.1136/bmj.2.5971.601 · Cited by 150
Roy, S. D., & Flynn, G. L. (1990) · Pharmaceutical Research · doi:10.1023/a:1015912932416 · Cited by 146
Dermatological And Transdermal Formulations
Walters, K. (2002) · Cited by 140
Estrogen replacement therapy by transdermal estradiol administration
Laufer, L. R., DEFAZIO, J., Lu, J. K. H., Meldrum, D. R., Eggena, P., Sambhi, M. P., Hershman, J. M., & Judd, H. L. (1983) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(83)90796-2 · Cited by 139
Transdermal nicotine reduces cigarette craving and nicotine preference
Rose, J., Herskovic, J. E., Trilling, Y., & Jarvik, M. E. (1985) · Clinical pharmacology and therapy · doi:10.1038/clpt.1985.203 · Cited by 138
Testosterone treatment comes of age: new options for hypogonadal men
Nieschlag, E. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02618.x · Cited by 137
Gratieri, T., Alberti, I., Lapteva, M., & Kalia, Y. N. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.03.019 · Cited by 133
Self-citationLefèvre, G. Y., Sedek, G., Jhee, S. S., Leibowitz, M. T., Huang, H.-L., Enz, A., Maton, S., Ereshefsky, L., Pommier, F., Schmidli, H., et al. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100242 · Cited by 130
TRANSDERMAL TESTOSTERONE SUBSTITUTION THERAPY FOR MALE HYPOGONADISM
Bals‐Pratsch, M., Yoon, Y., Knuth, U. A., & Nieschlag, E. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90600-8 · Cited by 127
Solubility and Related Physicochemical Properties of Narcotic Analgesics
Roy, S. D., & Flynn, G. L. (1988) · Pharmaceutical Research · doi:10.1023/a:1015994030251 · Cited by 122
Nachum, Z., Shupak, A., & Gordon, C. R. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645060-00001 · Cited by 120
Transdermal and Topical Drug Delivery Systems
Jasti, B., Abraham, W. H., & Ghosh, T. K. (2004) · CRC Press eBooks · doi:10.1201/9780203644478.ch14 · Cited by 117
Fotherby, K. (1996) · Contraception · doi:10.1016/0010-7824(96)00136-9 · Cited by 112
Effective use of transdermal drug delivery in children
Delgado-Charro, M. B., & Guy, R. H. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.014 · Cited by 105
Percutaneous Drug Absorption in the Newborn: Hazards and Uses
Rutter, N. (1987) · Clinics in Perinatology · doi:10.1016/s0095-5108(18)30740-1 · Cited by 104
Transdermal scopolamine in the prevention of motion sickness at sea
Price, N. M., Schmitt, L. G., McGuire, J., Shaw, J. E., & Trobough, G. (1981) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1981.57 · Cited by 103
Aspect of adhesives in transdermal drug delivery systems
Banerjee, S., Chattopadhyay, P., Ghosh, A., Datta, P., & Veer, V. (2014) · International Journal of Adhesion and Adhesives · doi:10.1016/j.ijadhadh.2014.01.001 · Cited by 102
McBride, J. S., Altman, D. G., Klein, M., & White, W. L. (1998) · Tobacco Control · doi:10.1136/tc.7.3.294 · Cited by 98
Crandall, L. A., Leake, C. D., Loevenhart, A. S., & Muehlberger, C. W. (1931) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09116-5 · Cited by 95
Skin tolerability associated with transdermal drug delivery systems: an overview
Ale, I. S., Lachapelle, J., & Maïbach, H. I. (2009) · Advances in Therapy · doi:10.1007/s12325-009-0075-9 · Cited by 92
Transdermal fentanyl for postoperative pain management. A double-blind placebo study
Caplan, R. A. (1989) · JAMA · doi:10.1001/jama.261.7.1036 · Cited by 92
Virilization of Young Children After Topical Androgen Use by Their Parents
Kunz, G. J., Klein, K. O., Clemons, R. D., Gottschalk, M. E., & Jones, K. L. (2004) · PEDIATRICS · doi:10.1542/peds.114.1.282 · Cited by 90
Abrams, L. S., Skee, D. M., Natarajan, J., Wong, F. A., & Anderson, G. D. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01532.x · Cited by 90
Fant, R. V., Henningfield, J. E., Shiffman, S. S., Strahs, K. R., & Reitberg, D. P. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00399-3 · Cited by 86
Horton, R., Shinsako, J., & Forsham, P. H. (1965) · European Journal of Endocrinology · doi:10.1530/acta.0.0480446 · Cited by 82
Brown, L. (1988) · Annual Review of Medicine · doi:10.1146/annurev.med.39.1.221 · Cited by 82
Fatal Fentanyl Intoxication Following Excessive Transdermal Application
Edinboro, L. F., Poklis, A., Trautman, D., Lowry, S., Backer, R. C., & Harvey, C. (1997) · Journal of Forensic Sciences · doi:10.1520/jfs14196j · Cited by 80
Tapsoba, I., Arbault, S., Walter, P., et al. (2009) · Analytical Chemistry · doi:10.1021/ac902348g · Cited by 80
Adverse dermatologic reactions to transdermal drug delivery systems
Hogan, D. J., & Maibach, H. I. (1990) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(90)70113-v · Cited by 80
NICOTINE ABSORPTION BY WORKERS HARVESTING GREEN TOBACCO
Gehlbach, S. H. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92829-9 · Cited by 76
Small doses, big problems: a selected review of highly toxic common medications.
Liebelt, E. L., & Shannon, M. W. (1993) · PubMed · Cited by 75
Programmed, systemic drug delivery by the transdermal route
Shaw, J. E., & Urquhart, J. (1979) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(79)90073-7 · Cited by 72
Bogaert, M. G. (1987) · Clinical Pharmacokinetics · doi:10.2165/00003088-198712010-00001 · Cited by 72
Pharmacokinetics and Oral Bioavailability of Scopolamine in Normal Subjects
Putcha, L., Cintrón, N. M., Tsui, J. K., Vanderploeg, J. M., & Kramer, W. G. (1989) · Pharmaceutical Research · doi:10.1023/a:1015916423156 · Cited by 71
Täuber, U., Schröder, K., Düsterberg, B., & Matthes, H. (1986) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03189840 · Cited by 67
Lefèvre, G. Y., Sedek, G., Huang, H. A., Saltzman, M. A., Rosenberg, M. A., Kiese, B., & Fordham, P. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006297748 · Cited by 64
Drug delivery devices : fundamentals and applications
Tyle, P. (1988) · Cited by 63
Azzaro, A. J., Ziemniak, J. A., Kemper, E. M., et al. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007304779 · Cited by 63
Small doses, big problems: A selected review of highly toxic common medications
LIEBELT, E. L., & SHANNON, M. W. (1993) · Pediatric Emergency Care · doi:10.1097/00006565-199310000-00008 · Cited by 63
Combination of behavioral smoking cessation with transdermal nicotine substitution
Buchkremer, G., Bents, H., Horstmann, M., Opitz, K., & Tölle, R. (1989) · Addictive Behaviors · doi:10.1016/0306-4603(89)90054-3 · Cited by 61
Self-citationThe Prevention and Treatment of Motion Sickness I. Seasickness
Gay, L. N., & Carliner, P. E. (1949) · Science · doi:10.1126/science.109.2832.359 · Cited by 60
Novel engineered systems for oral, mucosal and transdermal drug delivery
Li, H., Yu, Y., Dana, S. F., Li, B., Lee, C., & Kang, L. (2013) · Journal of drug targeting · doi:10.3109/1061186x.2013.805335 · Cited by 60
Transdermal drug pharmacokinetics in man: Interindividual variability and partial prediction
Farahmand, S., & Maïbach, H. I. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.11.020 · Cited by 60
A Sumatriptan Iontophoretic Transdermal System for the Acute Treatment of Migraine
Goldstein, J., Smith, T. R., Pugach, N., Griesser, J., Sebree, T. B., & Pierce, M. (2012) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2012.02198.x · Cited by 60
Transdermal Delivery Systems: A Medical Rationale
Cleary, G. W. (1993) · Springer eBooks · doi:10.1007/978-1-4899-1262-6_2 · Cited by 59
Transdermal administration of nicotine
Rose, J. E. (1984) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(84)90061-9 · Cited by 59
Pharmacokinetics of transdermally delivered clonidine
MacGregor, T. R., Matzek, K. M., Keirns, J. J., van Wayjen, R. G. A., van den Ende, A., & van Tol, R. G. L. (1985) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1985.171 · Cited by 58
Deaths After Intravenous Misuse of Transdermal Fentanyl
Lilleng, P. K., Mehlum, L., Bachs, L., & Morild, I. (2004) · Journal of Forensic Sciences · doi:10.1520/jfs2004143 · Cited by 57
Modelling Dermal Drug Distribution After Topical Application in Human
Anissimov, Y. G., & Roberts, M. S. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0437-2 · Cited by 57
Self-citationAndrogen therapy of hypogonadal men with transscrotal testosterone systems
Korenman, S. G., Viosca, S. P., Garza, D. E., Guralnik, M., Place, V. A., Campbell, P., & Davis, S. S. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90757-1 · Cited by 56
Transdermal enhancer patent literature
Santus, G., & Baker, R. W. (1993) · Journal of Controlled Release · doi:10.1016/0168-3659(93)90090-r · Cited by 52
Vanakoski, J., Seppälä, T., Sievi, E., & Lunell, E. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90057-0 · Cited by 50
Prevention of experimental motion sickness by scopolamine absorbed through the skin.
Graybiel, A., Knepton, J. C., & Shaw, J. E. (1976) · PubMed · Cited by 49
NICOTINE POISONING BY ABSORPTION THROUGH THE SKIN
Faulkner, J. M. (1933) · JAMA · doi:10.1001/jama.1933.02740210012005 · Cited by 47
The Effectiveness of Dramamine in the Prevention of Airsickness
STRICKLAND, B. A., & Hahn, G. L. (1949) · Science · doi:10.1126/science.109.2832.359-a · Cited by 46
Transdermal Delivery of Buprenorphine through Cadaver Skin
Roy, S. D., Roos, E., & Sharma, K. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830204 · Cited by 45
Transdermal delivery and the premature neonate.
Barrett, D. A., & Rutter, N. (1994) · PubMed · Cited by 40
Magner, L. N. (2005) · CRC Press eBooks · doi:10.1201/b14213 · Cited by 40
Transdermal and Topical Drug Delivery Today
Watkinson, A. C. (2011) · doi:10.1002/9781118140505.ch18 · Cited by 37
PREVENTION OF SEASICKNESS BY DRUGS
Holling, H. E., McArdle, B., & Trotter, W. R. (1944) · The Lancet · doi:10.1016/s0140-6736(00)42499-2 · Cited by 37
The Development of the Rotigotine Transdermal Patch
Waters, C. (2013) · Neurologic Clinics · doi:10.1016/j.ncl.2013.04.012 · Cited by 34
Farahmand, S., & Maïbach, H. I. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.03.028 · Cited by 34
Dermal and Transdermal Drug Delivery
Watkinson, A. C. (2008) · CRC Press eBooks · doi:10.3109/9781420045260-21 · Cited by 34
Analgesic efficacy of sustained release paracetamol in patients with osteoarthritis of the knee
Bacon, T. H., Hole, J., North, M., & Burnett, I. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01603.x · Cited by 33
Kanarkowski, R., Tornatore, K. M., DʼAmbrosio, R., et al. (1988) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1988.7 · Cited by 32
Comparison of the Pharmacokinetics of Two Nicotine Transdermal Systems: Nicoderm and Habitrol
Gupta, S., Okerholm, R. A., Eller, M. G., Wei, G. C. G., Rolf, C. N., & Gorsline, J. (1995) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1995.tb04093.x · Cited by 31
Smith, T. R., Goldstein, J., Singer, R., Pugach, N., Silberstein, S. D., & Pierce, M. (2012) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2012.02094.x · Cited by 31
Gorsline, J., Okerholm, R. A., Rolf, C. N., Moos, C. D., & Hwang, S. S. (1992) · The Journal of Clinical Pharmacology · doi:10.1177/009127009203200615 · Cited by 31
Kinetic Evaluation of Transdermal Nicotine Delivery Systems
Ho, H., & Chien, Y. W. (1993) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049309038769 · Cited by 30
Lund, F. K. (1948) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1948.tb12036.x · Cited by 30
Taggart, W. V., Dandekar, K. A., Ellman, H., & Notelovitz, M. (2000) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-200007050-00010 · Cited by 29
Correlations between motor persistence and plasma levels in methylphenidate-treated boys with ADHD
Greenhill, L. L., Perel, J. M., Rudolph, G. R., Feldman, B., Curran, S., Puig-Antich, J., & Gardner, R. A. (2001) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002413 · Cited by 28
MERCURIAL OINTMENTS IN THE TREATMENT OF SYPHILIS
COLE, H. N. (1930) · Archives of Dermatology and Syphilology · doi:10.1001/archderm.1930.01440090020002 · Cited by 27
Yu, Z., Gupta, S. K., Hwang, S. S., Cook, D. M., Duckett, M. J., & Atkinson, L. E. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04297.x · Cited by 27
DeVeaugh‐Geiss, A., Chen, L. H., Kotler, M. L., Ramsay, L. R., & Durcan, M. J. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.06.008 · Cited by 26
Sathyan, G., Guo, C. X., Sivakumar, K., Gidwani, S., & Gupta, S. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x65259 · Cited by 26
A commentary on transdermal drug delivery systems in clinical trials
Watkinson, A. C. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23490 · Cited by 25
Topically Applied Testosterone and Phallic Growth
Ben-Galim, E. (1980) · American journal of diseases of children · doi:10.1001/archpedi.1980.02130150050013 · Cited by 24
Holst, J. (1983) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016348309155363 · Cited by 23
Experimental motion sickness: efficacy of transdermal scopolamine plus ephedrine.
Graybiel, A., Cramer, D. B., & Wood, C. D. (1981) · PubMed · Cited by 18
de Oliveira, G. B., Hadgraft, J., & Lane, M. E. (2012) · Toxicology in Vitro · doi:10.1016/j.tiv.2012.02.007 · Cited by 15
Sobue, S., Sekiguchi, K., Kikkawa, H., & Irie, S. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005282632 · Cited by 12
Busse, K. L., & Maïbach, H. I. (2010) · Skin Pharmacology and Physiology · doi:10.1159/000321444 · Cited by 12
Pharmacokinetics of norethindrone acetate in women
Singh, H., Uniyal, J. P., Jha, P., Murugesan, K., Takkar, D., Hingorani, V., & Laumas, K. R. (1979) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(79)90715-4 · Cited by 9
Clonidine through the skin in the treatment of essential hypertension: is it practical?
Groth, H., Vetter, H., Knüsel, J., Boerlin, H. J., Walger, P., Baumgart, P., Wehling, M., Siegenthaler, W. E., & Vetter, W. (1983) · PubMed · Cited by 6
Cited by
Enhancement strategies for transdermal drug delivery systems: current trends and applications
Ramadon, D., McCrudden, M. T. C., Courtenay, A. J., & Donnelly, R. F. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00909-6 · Cited by 649
Permeation enhancers in transdermal drug delivery: benefits and limitations
Kováčik, A., Kopečná, M., & Vávrová, K. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1713087 · Cited by 369
Vaccination into the Dermal Compartment: Techniques, Challenges, and Prospects
Hettinga, J., & Carlisle, R. (2020) · Vaccines · doi:10.3390/vaccines8030534 · Cited by 72
Novel Therapy for Male Hypogonadism
Carrasquillo, R., Chu, K., & Ramasamy, R. (2018) · Current Urology Reports · doi:10.1007/s11934-018-0816-x · Cited by 31
Skin models of cutaneous toxicity, transdermal transport and wound repair
Vilela de Sousa, I., Ferreira, M. J. S., Bebiano, L. B., Simões, S., Matos, A. F., Pereira, R. F., & Granja, P. L. (2023) · Burns & Trauma · doi:10.1093/burnst/tkad014 · Cited by 17
Metadata
- Authors
- Pastore, M. N., Kalia, Y. N., Horstmann, M., & Roberts, M. S.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2015-03-18
- Volume
- 172
- Issue
- 9
- Pages
- 2179-2209
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2157286284
- Cited by
- 586
- References
- 130
- FWCI
- 12.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
